Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia From the Randomized, Controlled, Double-Blind ASPECT-NP Trial
mediaposted on 2020-09-28, 10:32 authored by Thomas Lodise, Joe Yang, Laura A. Puzniak, Ryan Dillon, Marin Kollef
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.